Back to Search Start Over

A survey on the use of gentamicin in infective endocarditis

Authors :
A. Elsendoorn
P. Roblot
F. Roblot
G. Le Moal
Serge Alfandari
Pierre Tattevin
Cendrine Godet
Guillaume Béraud
William Couet
Source :
European Journal of Clinical Microbiology & Infectious Diseases. 31:1413-1418
Publication Year :
2011
Publisher :
Springer Science and Business Media LLC, 2011.

Abstract

US and European guidelines recommend a daily divided gentamicin dose (3 mg/kg in two or three equally divided doses) for the treatment of infective endocarditis caused by staphylococci or enterococci, but once-daily dosing (3 mg/kg/day) is recommended for streptococcal endocarditis. However, studies have recommended the use of higher doses of gentamicin (4 or ≥5 mg/kg/day) administered once-daily. A survey was conducted in France by mailing a questionnaire to the 595 members of the French Infectious Disease Society regarding their gentamicin prescription patterns in infective endocarditis, focusing on the dosing regimen. The survey was answered by 137 physicians (23%). The proportions of physicians following guideline-based regimens were similar for each organism (30.9%, 38.8%, and 39.4% for staphylococci, enterococci, and streptococci, respectively [p=0.26]). In contrast, the proportions of physicians following literature-based regimens were significantly different for each organism (59.6%, 42.5%, and 27.7% for staphylococci, enterococci, and streptococci, respectively [p

Details

ISSN :
14354373 and 09349723
Volume :
31
Database :
OpenAIRE
Journal :
European Journal of Clinical Microbiology & Infectious Diseases
Accession number :
edsair.doi.dedup.....e3a1c65abef1e220bcd9e0e94a9a69db
Full Text :
https://doi.org/10.1007/s10096-011-1458-9